Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q85478508)
Watch
English
Bevacizumab in newly diagnosed ovarian cancer
scientific article published on 23 June 2015
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
26115795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26115795%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
title
Bevacizumab in newly diagnosed ovarian cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
26115795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26115795%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
main subject
bevacizumab
1 reference
based on heuristic
inferred from title
ovarian cancer
1 reference
based on heuristic
inferred from title
author
Ursula A. Matulonis
series ordinal
2
object named as
Ursula A Matulonis
1 reference
stated in
Europe PubMed Central
PubMed publication ID
26115795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26115795%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
author name string
Joyce F Liu
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
26115795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26115795%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
publication date
23 June 2015
1 reference
stated in
Europe PubMed Central
PubMed publication ID
26115795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26115795%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
published in
Lancet Oncology Commission
1 reference
stated in
Europe PubMed Central
PubMed publication ID
26115795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26115795%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
volume
16
1 reference
stated in
Europe PubMed Central
PubMed publication ID
26115795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26115795%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
issue
8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
26115795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26115795%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
page(s)
876-878
1 reference
stated in
Europe PubMed Central
PubMed publication ID
26115795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26115795%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
cites work
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900064-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase 3 trial of bevacizumab in ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900064-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Incorporation of bevacizumab in the primary treatment of ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900064-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900064-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900064-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label tr
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900064-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900064-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900064-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1470-2045(15)00064-9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
26115795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26115795%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
PubMed publication ID
26115795
1 reference
stated in
Europe PubMed Central
PubMed publication ID
26115795
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26115795%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit